In a model of BRAF, mutated CRC increased c-MET-STAT3 signaling was identified as a novel adaptive resistance mechanism to MEK inhibition resulting in increased transcription of the endogenous caspase-8 inhibitor c-FLIPL [203]. The gene discussed is MAP2K7; the disease is colorectal carcinoma.